Motley Fool Australia
  •  
  • Log Out
  • Menu
  1. Stocks
    2. /
  2. 4DMedical Ltd (ASX: 4DX)
    3. /

4DMedical Ltd (ASX: 4DX) Share Price and News

Price

$0.26

Movement

0.01 (-3.7%)

As at 1 Apr - Closed (20 mins delayed)

52 Week Range

$0.2675 - $0.715

 
1 Year Return

-60.0%

4DMedical Ltd Chart and Price Data

2025
2025
2025
2025
$0.25
$0.50
$0.75
$0.25
$0.50
$0.75
$0.25
$0.50
$0.75
$0.25
$0.50
$0.75

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $117.11 million
P/E Ratio N/A
Dividend Yield 0.00%
Shares Outstanding 450.42 million
Earnings per share -0.114
Dividend per share N/A
Year To Date Return -39.58%
Earnings Yield N/A
Franking -
Earnings Yield

N/A

Franking

-

Dividend per share

N/A

Year To Date Return

-39.58%

Shares Outstanding

450.42 million

Earnings per share

-0.114

Share Price

$0.26

Day Change

0.01 (-3.7%)

52 Week Range

$0.2675 - $0.715

Yesterday's Close

$0.27

Today's Open

$0.27

Days Range

$0.2525 - $0.27

Volume

1,617,934

Avg. Volume (1 month)

1,026,457

Turnover

$423,755

As at 1 Apr - Closed

    • 4DMedical Ltd (ASX: 4DX)
    Latest News

    Two smiling work colleagues discuss an investment or business plan at their office.
    Share Gainers

    Why 4DMedical, Orica, PSC Insurance, and REA shares are rising today

    | James Mickleboro

    These ASX shares are avoiding the market weakness on Thursday. But why?

    Read more »

    A man sees some good news on his phone and gives a little cheer.
    Share Gainers

    Why 4DMedical, Block, Judo, and Mesoblast shares are pushing higher today

    | James Mickleboro

    These ASX shares are avoiding the market weakness. But why?

    Read more »

    A man wearing a white coat and glasses is wide-mouthed in surprise.
    Healthcare Shares

    This ASX healthcare stock is up 12% in 2 days since All Ords inclusion: Should you buy?

    | James Mickleboro

    The latest member of the All Ordinaries index is getting some love this week.

    Read more »

    Man drawing an upward line on a bar graph symbolising a rising share price.
    Share Gainers

    Why 4DMedical, A2 Milk, QBE, and Zip shares are charging higher today

    | James Mickleboro

    These ASX shares are having a strong start to the week.

    Read more »

    Two happy excited friends in euphoria mood after winning in a bet with a smartphone in hand.
    Small Cap Shares

    2 exciting small-cap ASX shares that could rocket in 2024

    | James Mickleboro

    Analysts have put buy ratings on these small caps and see big potential returns.

    Read more »

    A young man wearing a black and white striped t-shirt looks surprised.
    Small Cap Shares

    Broker says these exciting small-cap ASX shares are buys

    | James Mickleboro

    These could be top options at the small side of the market.

    Read more »

    Happy diverse colleagues or team of people give high five together to celebrate great teamwork and results.
    Share Gainers

    Why 4DMedical, Iress, Premier Investments, and Tuas shares are pushing higher

    | James Mickleboro

    These ASX shares are ending the week on a high.

    Read more »

    A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face over these rising Tassal share price
    Share Market News

    Guess which ASX healthcare stock is rocketing on an 'unprecedented opportunity' with a global giant

    | James Mickleboro

    This healthcare stock is working closely with a giant in its field.

    Read more »

    A man pulls a shocked expression with mouth wide open as he holds up his laptop.
    Small Cap Shares

    Guess why these small cap ASX shares are jumping 10%+ today

    | James Mickleboro

    These small caps are making their shareholders smile on Monday.

    Read more »

    a doctor in white coat and stethoscope stands in front of a building holding an electronic device in his hands.
    Healthcare Shares

    This ASX medtech stock is roaring 67% higher today on a US approval

    | James Mickleboro

    Shareholders of this medtech stock are smiling on Monday.

    Read more »

    A man with a wide, eager smile on his face holds up three fingers.
    Small Cap Shares

    3 exciting small cap ASX shares brokers are tipping as buys

    | James Mickleboro

    Brokers are saying good things about these small cap shares in September.

    Read more »

    A young man wearing a black and white striped t-shirt looks surprised.
    Small Cap Shares

    Bell Potter rates these small cap ASX shares as buys

    | James Mickleboro

    These could be top options at the small side of the market.

    Read more »

    Frequently Asked Questions

    4DX ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    1st Apr 2025 2025-04-01T08:46:10 Letter to Shareholders, Notice of EGM & Proxy FormYesNo8:46am27605k
    26th Mar 2025 2025-03-26T09:58:04 Cost reduction program delivers $6.5m in annualised savingsYesNo9:58am3200k
    25th Mar 2025 2025-03-25T17:34:30 Target Market DeterminationYesNo5:34pm9163k
    25th Mar 2025 2025-03-25T17:31:45 ProspectusYesNo5:31pm45436k
    25th Mar 2025 2025-03-25T10:57:08 Application for quotation of securities - 4DXYesNo10:57am717k
    25th Mar 2025 2025-03-25T09:30:53 4DMedical completes oversubscribed $8.4m SPPYesNo9:30am3215k
    11th Mar 2025 2025-03-11T08:24:31 3-year contract extension secured with the Cleveland ClinicYesNo8:24am2192k
    3rd Mar 2025 2025-03-03T15:08:16 Notification of cessation of securities - 4DXYesNo3:08pm514k
    3rd Mar 2025 2025-03-03T14:55:31 Change of Director's Interest NoticeYesNo2:55pm3269k
    3rd Mar 2025 2025-03-03T14:55:26 Change of Director's Interest NoticeYesNo2:55pm4387k

    About 4DMedical Ltd

    4DMedical Ltd (ASX: 4DX) is a medical technology company working in the field of respiratory imaging and ventilation analysis in the treatment of lung and respiratory diseases.

    The company's non-invasive lung imaging technology emanates from research work undertaken at Monash University. It is the first FDA-cleared respiratory imaging solution that uses mathematical models and algorithms to convert sequences of X-ray images into four-dimensional quantitative data.

    The technology uses existing imaging systems and allows X-ray images to be taken simultaneously from various angles. Using image-processing methods adapted from aerospace engineering, the motion of lung tissue can be measured. This allows ventilation to be calculated at each stage of the breath and at every location within the lung. These measurements are then visualized as a coloured heat map to help medical professionals accurately identify ventilation deficits.

    The 4DMedical technology is patented in key jurisdictions, including the US and Australia. The company is aiming to secure a slice of the global lung imaging market. The US market alone was valued at more than $US30 billion in normal pre-COVID diagnostic conditions.

     

    4DX Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    31 Mar 2025 $0.27 $-0.02 -6.90% 1,746,176 $0.29 $0.29 $0.27
    28 Mar 2025 $0.29 $-0.03 -9.52% 2,050,460 $0.32 $0.32 $0.29
    27 Mar 2025 $0.32 $-0.01 -3.13% 1,148,787 $0.32 $0.32 $0.32
    26 Mar 2025 $0.32 $-0.04 -11.27% 2,593,834 $0.35 $0.35 $0.32
    25 Mar 2025 $0.36 $-0.01 -2.78% 1,129,206 $0.36 $0.37 $0.35
    24 Mar 2025 $0.36 $-0.02 -5.33% 771,570 $0.37 $0.38 $0.36
    21 Mar 2025 $0.38 $-0.01 -2.63% 116,874 $0.39 $0.39 $0.38
    20 Mar 2025 $0.38 $0.00 0.00% 92,664 $0.38 $0.38 $0.38
    19 Mar 2025 $0.38 $0.01 2.70% 306,052 $0.37 $0.38 $0.37
    18 Mar 2025 $0.37 $0.01 2.74% 432,840 $0.37 $0.38 $0.37
    17 Mar 2025 $0.37 $-0.01 -2.70% 627,813 $0.37 $0.37 $0.36
    14 Mar 2025 $0.37 $0.02 5.63% 249,854 $0.36 $0.37 $0.36
    13 Mar 2025 $0.36 $-0.01 -2.74% 1,073,898 $0.37 $0.37 $0.36
    12 Mar 2025 $0.37 $-0.01 -2.67% 747,183 $0.38 $0.38 $0.37
    11 Mar 2025 $0.38 $-0.02 -5.13% 1,148,713 $0.39 $0.39 $0.37
    10 Mar 2025 $0.39 $0.02 5.41% 1,268,278 $0.37 $0.40 $0.37
    07 Mar 2025 $0.37 $0.01 2.74% 1,783,125 $0.37 $0.38 $0.36
    06 Mar 2025 $0.37 $-0.01 -2.67% 964,991 $0.37 $0.38 $0.37
    05 Mar 2025 $0.38 $-0.01 -2.63% 1,145,242 $0.38 $0.38 $0.37
    04 Mar 2025 $0.38 $-0.01 -2.60% 1,311,667 $0.39 $0.39 $0.38

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    15 Jan 2025 Lilian (Lil) Bianchi Buy 105,649 $54,409
    Exercise of options.
    15 Jan 2025 Lilian (Lil) Bianchi Buy 91,257 $46,997
    Exercise of options.
    15 Jan 2025 Lilian (Lil) Bianchi Exercise 196,906 $101,406
    Exercise of options.
    15 Jan 2025 John Livingston Exercise 60,147 $30,975
    Exercise of options.
    15 Jan 2025 John Livingston Buy 60,147 $30,975
    Exercise of options.
    15 Jan 2025 Julian Sutton Exercise 60,147 $30,975
    Exercise of options.
    15 Jan 2025 Julian Sutton Buy 60,147 $30,975
    Exercise of options.
    14 Jan 2025 Geraldine McGinty Exercise 137,787 $71,649
    Conversion of securities.
    14 Jan 2025 Geraldine McGinty Buy 137,787 $71,649
    Conversion of securities.
    14 Jan 2025 Robert Figlin Buy 60,147 $31,276
    Conversion of securities.
    14 Jan 2025 Robert Figlin Exercise 60,147 $31,276
    Conversion of securities.
    21 Nov 2024 John Livingston Issued 60,147 $36,250
    Director remuneration.
    21 Nov 2024 Geraldine McGinty Issued 137,787 $72,500
    Director remuneration. VWAP, 137,787 Restricted Stock Units
    21 Nov 2024 Andreas Fouras Issued 775,339 $348,902
    Issue of options.
    21 Nov 2024 Julian Sutton Issued 60,147 $36,250
    Director remuneration.
    21 Nov 2024 Robert Figlin Issued 60,147 $36,250
    Issue of securities. vwap, 60,147 Restricted Stock Units
    21 Nov 2024 Lilian (Lil) Bianchi Issued 196,906 $104,327
    Director remuneration.
    07 Aug 2024 Andreas Fouras Expiry 914,000 $411,300
    Options expired.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr John Andrew Livingston Executive Director Mar 2018
    Mr Livingston was previously one of the founding partners of Lake Imaging, subsequently becoming part of Integral Diagnostics Ltd., where John was Chief Executive Officer and Managing Director.
    Dr Robert Alan Figlin Non-Executive Director Dec 2016
    Dr Figlin held the post of Medical Director of the Thoracic and Genitourinary Oncology Program in the Departments of Medicine, Surgery and Urology, and served as Program Director of Solid Tumor Developmental Therapeutics within the Cancer Center. Robert serves as Editor for Kidney Cancer Journal, and his studies have appeared in Clinical Cancer Research, Journal of Clinical Oncology, New England Journal of Medicine, The Lancet, JNCI, Lancet Oncology, and Journal of Urology, among others. He is Chair of the Medical Advisory Committee.
    Dr Andreas Fouras Chief Executive OfficerManaging Director Dec 2012
    Dr Fouras career in academic research has a foundation gained within studying experimental fluid dynamics in the Department of Mechanical and Aerospace Engineering at Monash University in Melbourne, Australia. This research into wind tunnel quantification garnered recognition as a young leader in the scientific discipline of fluid dynamics, developing a number of new approaches to the imaging of gas and liquid flow. He is member of the Medical Advisory Committee.
    Ms Lilian (Lil) Bianchi Non-Executive DirectorNon-Executive Chairman Dec 2019
    Ms Bianchi is an experienced Non-Executive Director with a focus on innovative companies operating in highly regulated environments including health, finance and infrastructure. She is Chair of the Risk Committee.
    Mr Julian Bernard Kingsley Sutton Non-Executive Director Sep 2017
    Mr Sutton began his career as an actuarial analyst for Towers Perrin in Melbourne where he consulted to some of Australia's largest superannuation funds. He later worked for Towers Perrin in Brussels and London as an asset consultant before moving to Credit Suisse Asset Management and then Schroders Investment Management as a portfolio manager in their respective multi-manager teams. He is member of Risk Committee.
    Dr Geraldine Bernadette McGinty Non-Executive Director Sep 2023
    Dr McGinty is an expert in health care strategy and imaging economics, and prominent advocate for patient-centred care. A Professor of Clinical Radiology and Population Health Sciences at Weill Cornell Medicine in New York City, she serves as Senior Associate Dean for Clinical Affairs. He is member of the Medical Advisory Committee.
    Mr Hamish George Company Secretary Mar 2025
    -
    Matt Tucker Chief Commercial Officer
    -
    Simon Glover Chief Financial Officer
    -
    Hamish George Company Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Velocimetry Consulting Pty Ltd 64,838,000 15.79%
    Citicorp Nominees Pty Limited 23,268,218 5.67%
    BNP Paribas Nominees Pty Ltd 19,897,389 4.85%
    HSBC Custody Nominees (Australia) Limited 14,435,511 3.52%
    Ryder Innovation Fund LP 4,551,274 1.11%
    HSBC Custody Nominees (Australia) Limited A/C 2 4,179,399 1.02%
    Merrill Lynch (Australia) Nominees Pty Limited 3,573,454 0.87%
    Mr Damen Diamantopoulos 3,090,000 0.75%
    JP Morgan Nominees Australia Pty Limited 2,806,425 0.68%
    Alex Petrou & Christine Petrou 2,484,471 0.61%
    Mr Paul Tomlin 2,416,870 0.59%
    BNP Paribas Noms Pty Ltd 2,101,511 0.51%
    Pacific Custodians Pty Limited 2,040,978 0.50%
    Mrs Irene Wai-Ping Lee & Miss Yvonne Lee & Mr Wilson Lee 1,997,346 0.49%
    Sprout Group Pty Ltd 1,769,331 0.43%
    BNP Paribas Nominees Pty Ltd i 1,737,816 0.42%
    Mr Dev Jayram 1,580,583 0.39%
    Fang Family Investments Pty Ltd 1,517,437 0.37%
    Endless Smiles Pty Ltd 1,500,000 0.37%
    Wal Assets Pty Ltd 1,411,487 0.34%

    Profile

    since

    Note